NO180517C - Fremgangsmåte for fremstilling av en fast, farmasöytisk enhetsformulering - Google Patents
Fremgangsmåte for fremstilling av en fast, farmasöytisk enhetsformuleringInfo
- Publication number
- NO180517C NO180517C NO902280A NO902280A NO180517C NO 180517 C NO180517 C NO 180517C NO 902280 A NO902280 A NO 902280A NO 902280 A NO902280 A NO 902280A NO 180517 C NO180517 C NO 180517C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pct
- solid pharmaceutical
- pharmaceutical unit
- unit formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 abstract 1
- 229960004801 imipramine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Materials For Medical Uses (AREA)
- Filtering Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8906781A FR2647343B1 (fr) | 1989-05-24 | 1989-05-24 | Nouvelle forme pharmaceutique poreuse et sa preparation |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO902280D0 NO902280D0 (no) | 1990-05-23 |
| NO902280L NO902280L (no) | 1990-11-26 |
| NO180517B NO180517B (no) | 1997-01-27 |
| NO180517C true NO180517C (no) | 1997-05-07 |
Family
ID=9381955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO902280A NO180517C (no) | 1989-05-24 | 1990-05-23 | Fremgangsmåte for fremstilling av en fast, farmasöytisk enhetsformulering |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5244881A (en:Method) |
| EP (2) | EP0399902B1 (en:Method) |
| JP (1) | JP2948271B2 (en:Method) |
| KR (1) | KR0163423B1 (en:Method) |
| AT (2) | ATE83663T1 (en:Method) |
| AU (2) | AU623779B2 (en:Method) |
| CA (2) | CA2017360A1 (en:Method) |
| DD (1) | DD297915A5 (en:Method) |
| DE (2) | DE69000641T2 (en:Method) |
| DK (2) | DK0399902T3 (en:Method) |
| ES (2) | ES2062437T3 (en:Method) |
| FI (1) | FI103712B1 (en:Method) |
| FR (1) | FR2647343B1 (en:Method) |
| GR (1) | GR3006655T3 (en:Method) |
| IE (2) | IE64370B1 (en:Method) |
| IL (2) | IL94460A0 (en:Method) |
| NO (1) | NO180517C (en:Method) |
| NZ (2) | NZ233766A (en:Method) |
| PL (1) | PL285327A1 (en:Method) |
| PT (2) | PT94139B (en:Method) |
| TW (1) | TW257672B (en:Method) |
| WO (1) | WO1990014089A1 (en:Method) |
| YU (1) | YU100790A (en:Method) |
| ZA (2) | ZA903895B (en:Method) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE196426T1 (de) * | 1991-06-21 | 2000-10-15 | Takeda Chemical Industries Ltd | Zyklodextrin-zusammensetzung enthaltend fumagillol-derivate |
| KR100256147B1 (ko) | 1991-12-24 | 2000-08-01 | 오노다 마사요시 | 구강내 붕해성 제제 및 이의 제조방법 |
| GB9318880D0 (en) * | 1993-09-11 | 1993-10-27 | Smithkline Beecham Plc | Pharmaceutical composition |
| EP0760680A1 (en) * | 1994-05-27 | 1997-03-12 | Farmarc Nederland Bv | Pharmaceutical composition |
| DE69840495D1 (de) * | 1997-02-20 | 2009-03-12 | Massachusetts Inst Technology | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben |
| BE1011251A3 (fr) * | 1997-07-03 | 1999-06-01 | Ucb Sa | Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine. |
| TW527195B (en) | 1997-10-09 | 2003-04-11 | Ssp Co Ltd | Fast-soluble solid pharmaceutical combinations |
| AU753519B2 (en) * | 1998-02-05 | 2002-10-17 | Novartis Ag | Compositions containing organic compounds |
| IT1304190B1 (it) * | 1998-12-18 | 2001-03-08 | Euphar Group Srl | Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche |
| US6287603B1 (en) * | 1999-09-16 | 2001-09-11 | Nestec S.A. | Cyclodextrin flavor delivery systems |
| JP4724367B2 (ja) | 2002-01-15 | 2011-07-13 | ユセベ ファルシム ソシエテ アノニム | 処方 |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| BR0307935A (pt) | 2002-02-25 | 2005-03-29 | Diffusion Pharmaceuticals Llc | Sais de trans carotenóide bipolares e seus usos |
| DE10239531A1 (de) * | 2002-08-23 | 2004-03-04 | Gulbins, Erich, Prof. Dr. | Prophylaxe und Therapie von Infektionserkrankungen |
| DE10248314A1 (de) * | 2002-10-16 | 2004-04-29 | Dr. Suwelack Skin & Health Care Ag | Verwendung von Formkörpern zur äußeren Anwendung |
| FR2876910B1 (fr) * | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction |
| US8030350B2 (en) * | 2005-02-24 | 2011-10-04 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
| DE102005041860A1 (de) * | 2005-09-02 | 2007-03-08 | Schering Ag | Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen |
| EP2146948A4 (en) | 2007-04-13 | 2010-08-04 | Diffusion Pharmaceuticals Llc | USE OF BIPOLAR TRANS-CAROTINOIDES AS PRE-TREATMENT AND TREATMENT OF PERIPHERAL VASCULAR DISEASE |
| JP2009091309A (ja) * | 2007-10-10 | 2009-04-30 | Japan Organo Co Ltd | バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品 |
| WO2009058399A1 (en) | 2007-10-31 | 2009-05-07 | Diffusion Pharmaceuticals Llc | A new class of therapeutics that enhance small molecule diffusion |
| AU2009288006B2 (en) * | 2008-09-05 | 2014-07-17 | Mcneil-Ppc, Inc. | Method for making cetirizine tablets |
| EP3539542B1 (en) | 2009-06-22 | 2023-04-19 | Diffusion Pharmaceuticals LLC | Diffusion enhancing compounds and their use with a thrombolytic |
| CN103124498A (zh) | 2010-06-02 | 2013-05-29 | 扩散药品有限公司 | 双极性反式类胡萝卜素的口服制剂 |
| EP3210597A1 (en) * | 2010-09-13 | 2017-08-30 | Bev-RX, Inc. | Aqueous drug delivery system comprising off- flavor masking agent |
| RU2609198C1 (ru) * | 2016-01-25 | 2017-01-30 | Закрытое Акционерное Общество "БИОКОМ" | Твердая лекарственная форма имипрамина немедленного высвобождения и способ ее получения |
| JP7032320B2 (ja) | 2016-03-24 | 2022-03-08 | ディフュージョン・ファーマシューティカルズ・エルエルシー | 癌を処置するための、化学療法及び放射線療法を伴う二極性トランスカロテノイドの使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5443570B2 (en:Method) * | 1972-10-27 | 1979-12-20 | ||
| IE45770B1 (en) * | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
| US4165382A (en) * | 1977-10-17 | 1979-08-21 | Jose Pozuelo | Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine |
| US4284555A (en) * | 1979-04-27 | 1981-08-18 | Schering Corporation | 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4349472A (en) * | 1979-04-27 | 1982-09-14 | Schering Corporation | (S)-8(1-Adamantanecarbonyloxy)-7-chloro-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| US4477378A (en) * | 1980-02-05 | 1984-10-16 | Schering Corp. | Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| WO1986003198A1 (fr) * | 1984-11-27 | 1986-06-05 | Dainippon Pharmaceutical Co., Ltd. | Derives de 2-(1-piperazinyle)-4-substitue phenylquinoline, procede de preparation et composition medicinale les contenant |
| GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
| GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
-
1989
- 1989-05-24 FR FR8906781A patent/FR2647343B1/fr not_active Expired - Fee Related
-
1990
- 1990-05-21 IL IL94460A patent/IL94460A0/xx unknown
- 1990-05-21 ZA ZA903895A patent/ZA903895B/xx unknown
- 1990-05-21 IE IE182190A patent/IE64370B1/en not_active IP Right Cessation
- 1990-05-21 IL IL9445990A patent/IL94459A/en not_active IP Right Cessation
- 1990-05-22 KR KR1019900007369A patent/KR0163423B1/ko not_active Expired - Fee Related
- 1990-05-22 ES ES90401369T patent/ES2062437T3/es not_active Expired - Lifetime
- 1990-05-22 ES ES90401370T patent/ES2054289T3/es not_active Expired - Lifetime
- 1990-05-22 AU AU55828/90A patent/AU623779B2/en not_active Ceased
- 1990-05-22 DE DE9090401370T patent/DE69000641T2/de not_active Expired - Fee Related
- 1990-05-22 WO PCT/FR1990/000359 patent/WO1990014089A1/fr not_active Ceased
- 1990-05-22 NZ NZ233766A patent/NZ233766A/xx unknown
- 1990-05-22 AT AT90401370T patent/ATE83663T1/de not_active IP Right Cessation
- 1990-05-22 EP EP90401369A patent/EP0399902B1/fr not_active Expired - Lifetime
- 1990-05-22 DK DK90401369.5T patent/DK0399902T3/da active
- 1990-05-22 DE DE90401369T patent/DE69005359T2/de not_active Expired - Lifetime
- 1990-05-22 AT AT90401369T patent/ATE98867T1/de not_active IP Right Cessation
- 1990-05-22 AU AU57433/90A patent/AU631888B2/en not_active Ceased
- 1990-05-22 EP EP90401370A patent/EP0399903B1/fr not_active Expired - Lifetime
- 1990-05-22 US US07/776,344 patent/US5244881A/en not_active Expired - Fee Related
- 1990-05-22 DK DK90401370.3T patent/DK0399903T3/da active
- 1990-05-23 FI FI902553A patent/FI103712B1/fi not_active IP Right Cessation
- 1990-05-23 PT PT94139A patent/PT94139B/pt not_active IP Right Cessation
- 1990-05-23 IE IE186290A patent/IE63317B1/en not_active IP Right Cessation
- 1990-05-23 YU YU01007/90A patent/YU100790A/xx unknown
- 1990-05-23 JP JP2131437A patent/JP2948271B2/ja not_active Expired - Lifetime
- 1990-05-23 ZA ZA903978A patent/ZA903978B/xx unknown
- 1990-05-23 DD DD90340952A patent/DD297915A5/de not_active IP Right Cessation
- 1990-05-23 CA CA002017360A patent/CA2017360A1/fr not_active Abandoned
- 1990-05-23 NO NO902280A patent/NO180517C/no unknown
- 1990-05-23 CA CA002017355A patent/CA2017355A1/fr not_active Abandoned
- 1990-05-23 PT PT94138A patent/PT94138B/pt not_active IP Right Cessation
- 1990-05-23 NZ NZ233784A patent/NZ233784A/xx unknown
- 1990-05-24 PL PL28532790A patent/PL285327A1/xx unknown
- 1990-05-30 TW TW079104379A patent/TW257672B/zh active
-
1992
- 1992-12-24 GR GR920401770T patent/GR3006655T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO180517C (no) | Fremgangsmåte for fremstilling av en fast, farmasöytisk enhetsformulering | |
| NZ244021A (en) | Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof | |
| NZ229832A (en) | Condensed heterocyclic compounds, preparation and pharmaceutical compositions thereof | |
| ES2157993T3 (es) | Benzoilguanidinas, su preparacion y su uso en medicamentos. | |
| AR018197A1 (es) | Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento | |
| MY101566A (en) | Pharmaceutical compositions. | |
| BR9201253A (pt) | Composto,processo para a sua preparacao,agente diagnostico ou terapeutico e aplicacao do mencionado composto | |
| DK0387821T3 (da) | 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed | |
| ATE213633T1 (de) | Lamotrigin haltiges arzneimittel | |
| IT8621097A1 (it) | Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche | |
| MX9202432A (es) | Compuestos de 4,5-dihidro-1,4-benzotiazepin-3(2h)onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
| ITMI912550A0 (it) | Derivato di mentile,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono | |
| ATE49956T1 (de) | N,n-bis-(4fluorophenyl)carbamoylacetohydroxams|ure und diese enthaltende pharmazeutische zusammensetzungen. |